August 29, 2019— Dartmouth-Hitchcock Health is a small but vital health system serving some very rural areas of northern New Hampshire and Vermont. Despite its relatively remote region, the system is home to a renowned academic medical center, a cancer institute, and the only level 1 trauma center in New Hampshire. Through participation in the 340B drug discount program by … [Read more...]
340B Goes Back to School
August 23, 2019— When one considers the types of patients who benefit the most from the 340B drug pricing program, one might think first of adults with chronic illnesses who have low incomes or who live in rural areas. But many individuals who also rely on 340B as part of the health care safety net are some of the youngest patients among us. Part of the great power of 340B … [Read more...]
Faces of 340B: Hiring Exceptional People
August 16, 2019— As a critical access hospital, RiverView Health in northwest Minnesota is a vital source of care for the largely rural communities it serves. That necessitates hiring physicians and other health professionals who can provide high-quality services to their patients, says Betty Arvidson, the hospital’s chief financial officer. “We have a mission to provide … [Read more...]
Pillars of Care: Five Important Ways That Medicaid and 340B Are Alike
by Maureen Testoni June 20, 2019– Web headlines such as “10 Things You Missed in the Game of Thrones Finale!’” are the epitome of clickbait, but they are effective in getting people’s attention. So let’s try this: Can you name the five important ways that Medicaid and the 340B drug pricing program are alike? The answers might surprise you! Even most casual observers know … [Read more...]
Five Ways 340B Hospitals are Using Savings for Patients
June 12, 2019— As policymakers debate the future of the 340B drug pricing program, a new report by 340B Health finds that hospitals are using the savings from outpatient prescription drug discounts to care for patients with low incomes and those living in underserved rural communities. The report is based on a survey of more than 1,300 hospitals participating in … [Read more...]
340B Key to Trump Administration’s HIV Strategy
April 25, 2019— President Trump’s ambitious campaign to end the HIV epidemic in the U.S. will rely heavily on the 340B drug pricing program, according to senior administration officials. A key focus of the effort is to connect people at risk of HIV infection to pre-exposure prophylaxis (PrEP), a treatment that can cost nearly $2,000 a month. In his State of the Union … [Read more...]
340B Hospitals Serve a Vital Role in Combatting Opioid Epidemic
January 23, 2019– Since 1999, more than 700,000 Americans have lost their lives to a drug overdose, and care for people affected by this epidemic has added an estimated $1 trillion to the U.S. healthcare bill. According to the CDC, in 2017 more than 70,000 opioid-related deaths were the main contributor to a decline in U.S. life expectancy. Confronting the nation’s opioid … [Read more...]